Frank Valone

Title: Frank Valone: Innovator in Cancer Therapeutics

Introduction

Frank Valone is a notable inventor based in Mill Valley, CA (US), recognized for his contributions to the field of cancer therapeutics. With a focus on innovative methods for treating pancreatic cancer, Valone has made significant strides in improving patient outcomes through his patented inventions. He holds 2 patents that reflect his dedication to advancing medical science.

Latest Patents

Valone's latest patents include a therapeutic method for pancreatic cancer, which relates to methods and medicaments useful for treating locally advanced pancreatic cancer (LAPC). This invention provides improved therapeutic methods and regimens that comprise anti-connective tissue growth factor (CTGF) agents, including anti-CTGF antibodies. The patent also outlines induction therapies aimed at converting unresectable LAPC into borderline or resectable status. Another significant patent describes methods for treating CTGF-associated cancers, including pancreatic cancer, using an anti-CTGF antibody, demonstrating that increased antibody exposure can improve patient outcomes.

Career Highlights

Valone's career is marked by his work at Fibrogen, Inc., where he has been instrumental in developing innovative cancer treatments. His research and inventions have contributed to the understanding and management of pancreatic cancer, a disease known for its challenging prognosis.

Collaborations

Some of Valone's notable coworkers include Katharina Modelska and Vincent Picozzi, who have collaborated with him in advancing research in cancer therapeutics.

Conclusion

Frank Valone's work exemplifies the impact of innovation in the medical field, particularly in the treatment of pancreatic cancer. His patents and research efforts continue to pave the way for improved therapeutic options for patients facing this challenging disease.